Capital Signal

Recce Pharmaceuticals LTD (ASX: RCE)

Sector: Health Care

Market cap: A$110M (as of 2 Nov 2026)

Pharmaceutical research and development.

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
31 July 2026SPP$2.4M$0.40—Filing ↗
26 June 2026Placement$8M$0.4013% discountFiling ↗
3 June 2025Placement$7.4M$0.28—Filing ↗
16 May 2025Rights issue$3.4M$0.28—Filing ↗
10 Apr 2025Rights issue$10.8M$0.2813.8% discountFiling ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
29 Aug 2025Mr Gavin William BrownEntry?% → 13.68%Filing ↗
24 July 2025Mr Gavin William BrownIncrease12.39% → 13.68%Filing ↗
12 June 2025FIL Limited and its entities listed in Annexure AIncrease6.4% → 8.57%Filing ↗
11 June 2025Gavin William Brown (GWB)Increase7.16% → 12.39%Filing ↗
6 June 2025Mr Gavin William BrownEntry—Filing ↗

Director trades — on-market

DateDirectorTradeSource
22 June 2023James Hamilton Bray GrahamBought 500,000 fully paid ordinary sharesFiling ↗
16 June 2021Ms Michele Keryn DiliziaSold 175,000 ordinary sharesFiling ↗
16 June 2021James Hamilton Bray GrahamBought 47,850 fully paid ordinary sharesFiling ↗
8 Aug 2019Ms Michele Keryn DiliziaSold 45,000 fully paid ordinary sharesFiling ↗
7 Aug 2019Ms Michele Keryn DiliziaSold 277,000 fully paid ordinary sharesFiling ↗

Cash and runway

MetricValueAs ofSource
CashA$1M30 Sept 2026Filing ↗
Runway5.6 quarters30 Sept 2026Filing ↗

Ask about RCE in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has RCE raised money in the last year, and at what discount?
  • What was RCE's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading RCE…

Recce Pharmaceuticals LTD (ASX: RCE): capital raises, holders, director trades | Capital Signal